Faculty and staff directory

W. Andrew Yeudall, B.D.S., Ph.D., F.R.C.Path

W. Andrew Yeudall, B.D.S., Ph.D., F.R.C.Path

Associate professor and director of basic dental science education

Philips Institute of Oral and Craniofacial Molecular Biology
W. Baxter Perkinson Jr. Building
1101 East Leigh Street
Box 980566
Richmond, Virginia 23298-0566
Phone: (804) 828-6415
Fax: (804) 828-0150
Email: wayeudall@vcu.edu


Education

  • F.R.C.Path in Oral Pathology, Royal College of Pathologists, 2013
  • Ph.D. in Molecular Biology, University of Glasgow, 1991
  • B.D.S., University of Glasgow, 1986
  • B.Sc. in Biochemistry, University of Glasgow, 1983

Professional affiliations

  • International Academy of Oral Oncology
  • Royal College of Pathologists

Research interests

  • Diagnostic and predictive markers for squamous cell carcinoma
  • Cell cycle regulation
  • Growth factor signaling

Publications

Bulysheva AA, Yeudall WA. Eps8 (epidermal growth factor receptor pathway substrate 8). Atlas Genet Cytogenet Oncol Haematol. 2011
 
Wang H, et al. Role for EPS8 in squamous carcinogenesis. Carcinogenesis 30, 165-174 (2009)

Paccione RJ, et al. Keratin downregulation in vimentin-positive cancer cells is reversible by vimentin RNAi, which inhibits growth and motility. Mol Cancer Ther 7, 2894-2903 (2008)

Yeudall WA. Squamous cell carcinoma. Encyclopedia of Cancer. Ed. M. Schwab. Springer, Berlin. pp 2798-2801 (2008)

Christofakis E, et al. Roles of CXCL8 in squamous carcinoma proliferation and migration. Oral Oncol 44, 920-926 (2008)

Tripathi A, et al. Docking and hydropathic scoring of polysubstituted pyrrole compounds with anti-tubulin activity. Bioorgan Med Chem 16, 2235–2242 (2008)

Molinolo A, et al. Dissecting the Akt/mTOR signaling network: emerging results from the head and neck cancer tissue array initiative. Clin Cancer Res 13, 4964-4973 (2007)

Arthur C, et al. Autophagic cell death, polyploidy and senescence induced in breast tumor cells by the substituted pyrrole JG-03-14, a novel microtubule poison. Biochem Pharmacol 74, 981-991 (2007)

Yeudall WA, Miyazaki H. Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention? Expert Rev Anticancer Therapy. 7, 351-360 (2007).

Miyazaki H, et al. Downregulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res 66, 4279-4284 (2006)

Miyazaki H, et al. Growth factor-sensitive molecular targets identified in primary and metastatic head and neck squamous cell carcinoma using microarray analysis. Oral Oncology 42, 240-256 (2006)

Edmiston JS, et al. Inability of TGFβ to cause SnoN degradation in esophageal cancer cells leads to resistance to TGFβ induced growth arrest. Cancer Res 65, 4782-4788 (2005)

Yeudall WA, et al. Uncoupling of epidermal growth factor-dependent proliferation and invasion in a model of squamous carcinoma progression. Oral Oncol 41, 698-708 (2005)

Wrighton KH, et al. Aberrant p53 alters DNA damage checkpoints in response to cisplatin: downregulation of CDK expression and activity. Int J Cancer 112, 760-770 (2004)